Kessler Topaz Investigates uniQure N.V. After Stock Plunge Related to FDA Concerns

Investigating uniQure N.V.: Kessler Topaz's Call to Action for Investors

The law firm Kessler Topaz Meltzer & Check, LLP is currently delving into potential violations of federal securities laws on behalf of investors impacted by significant drops in the stock price of uniQure N.V. This investigation is particularly relevant following the company’s announcement earlier this month regarding the FDA's feedback on its investigational gene therapy, AMT-130.

On November 3, 2025, uniQure disclosed that the FDA has not found sufficient evidence to support its Biologics License Application (BLA) for AMT-130, a treatment aimed at Huntington's disease. Specifically, the company revealed that the FDA no longer aligns with their expectation that data from Phase I/II studies of AMT-130 could justify a BLA submission. This revelation has cast uncertainty on the timeline for the BLA and has left investors in a precarious position.Prior to the news, on October 31, 2025, uniQure's stock closed at $67.69, but by November 3, it plummeted to $34.29, marking a staggering decrease of over 50%.

This dramatic decline has prompted Kessler Topaz to reach out to affected investors. The firm invites those who have suffered considerable losses to connect with their legal team. Interested investors can complete an online form or contact the firm directly to discuss their circumstances and explore potential legal recourse.

Kessler Topaz, renowned for its advocacy in corporate governance, has previously recovered billions on behalf of both institutional and individual investors facing securities fraud, breaches of fiduciary duties, and other violations of state and federal laws. In a landscape where investor trust can be easily shaken, their current investigation into uniQure seems to be an important move towards accountability.

If you're an investor in uniQure and are looking for more information regarding this investigation and possible next steps, you are encouraged to visit the law firm's website or give them a call. The contact details are readily available, and their team stands ready to assist you through this troubling time.

Kessler Topaz Meltzer & Check, LLP has a history of representing not just investors but also consumers and whistleblowers who bring light to fraudulent practices. Their commitment to supporting individuals who have been wronged in these situations serves as a reminder of the importance of due diligence and investor rights.

Conclusion

As the legal landscape around securities fraud continues to evolve, it is crucial for investors to stay informed and proactive, especially in light of recent events surrounding uniQure N.V. The guidance of experienced firms like Kessler Topaz can provide crucial support in navigating these challenges and seeking redress for financial losses. If you are affected, do not hesitate to reach out to them for assistance.